多形性小叶原位癌:影像特征、升级率与临床结局
回顾性单机构研究纳入1999年1月1日至2016年7月20日空心针活检或切除活检诊断为多形性小叶原位癌且无伴发导管原位癌或浸润性癌的女性,评估影像表现、空心针活检后升级率及治疗结局。空心针活检诊断的15例中4例(27%;95% CI,4-49%)在肿块切除时升级为导管原位癌或浸润性癌;纯多形性小叶原位癌最常见表现为钼靶细多形性钙化(16例中13例,81%)。结论认为空心针活检诊断多形性小叶原位癌需手术切除。
要点
- 空心针活检诊断的多形性小叶原位癌升级率为27%(4/15;95% CI,4-49%),升级为导管原位癌或浸润性癌。
- 纯多形性小叶原位癌最常见钼靶表现为细多形性钙化(16例中13例,81%)。
- 无独特钼靶特征可预测需升级或病变范围。
核心结论
- 多形性小叶原位癌最常见表现为钼靶细多形性钙化,空心针活检后升级率高;空心针活检诊断多形性小叶原位癌需手术切除。
研究设计与样本
- 回顾性单机构研究,纳入1999年1月1日至2016年7月20日空心针活检(16例)或切除活检(5例)诊断为多形性小叶原位癌且无伴发导管原位癌或浸润性癌的女性共21例,回顾影像、检测方式、治疗与结局,计算肿块切除时升级为导管原位癌或浸润性癌的升级率。
关键影像表现/征象
- 纯多形性小叶原位癌(未升级)16例中13例(81%)在筛查钼靶上表现为细多形性钙化。
- 纯多形性小叶原位癌16例中1例(6%)表现为结构扭曲伴钙化,1例(6%)表现为肿块,1例(6%)表现为MRI非肿块强化。
- 中位影像大小11 mm(均值14 mm;范围3-47 mm)。
诊断标准与关键数值
- 空心针活检诊断多形性小叶原位癌的升级率:15例中4例升级(27%;95% CI,4-49%),其中2例升级为导管原位癌、2例升级为浸润性小叶癌(1例患者拒绝切除)。
临床应用与阅片要点
- 空心针活检诊断为多形性小叶原位癌时,原文结论为需手术切除。
- 纯多形性小叶原位癌在筛查钼靶上最常见为细多形性钙化,但无独特钼靶特征可预测需升级或病变范围。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Pleomorphic lobular carcinoma in situ (PLCIS) is an aggressive subtype of lobular carcinoma in situ treated similarly to ductal carcinoma in situ. The purpose of this study was to determine the imaging findings, upgrade rate of PLCIS at core needle biopsy (CNB), and the treatment and outcomes of these patients.
MATERIALS AND METHODS: This retrospective single-institution study included women with PLCIS at CNB or excisional biopsy without concomitant DCIS or invasive carcinoma between January 1, 1999, and July 20, 2016. Imaging findings, detection mode, treatment, and outcomes were reviewed. Retrospective review of the images was performed. Upgrade rate to ductal carcinoma in situ or invasive carcinoma at lumpectomy was calculated.
RESULTS: Twenty-one patients had a finding of PLCIS at CNB (n = 16) or excisional biopsy (n = 5). Four of 15 (27%; 95% CI, 4-49%) cases of PLCIS at CNB were upgraded to DCIS (two cases) or invasive lobular cancer (two cases) at lumpectomy (one patient declined excision). No unique mammographic features were predictive of need to upgrade or extent of disease. Among the patients with pure PLCIS (not upgraded), 13 of 16 (81%) presented with fine pleomorphic calcifications on screening mammograms, 1 of 16 (6%) with distortion and calcifications, 1 of 16 (6%) with a mass, and 1 of 16 (6%) with nonmass enhancement at MRI. The median imaging size was 11 mm (mean, 14 mm; range, 3-47 mm). Twelve of 16 (75%) patients were treated with lumpectomy and 4 of 16 (25%) with mastectomy. Eight of 16 (50%) patients received adjuvant hormonal therapy, and 2 of 16 (17%) received radiation. There were no local recurrences.
CONCLUSION: PLCIS most commonly presented as fine pleomorphic calcifications on mammograms and had a high upgrade rate after CNB. CNB diagnosis of PLCIS requires surgical excision.
引用
- Savage JL, Jeffries DO, Noroozian M, et al. Pleomorphic Lobular Carcinoma In Situ: Imaging Features, Upgrade Rate, and Clinical Outcomes. AJR Am J Roentgenol. 2018. PMID: 29894223. doi:10.2214/AJR.17.19088
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。